Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial

European Journal of Cancer

Volumn 37, Issue 17, 2001, Pages 2154-2160

  Miller, A B ^a   Madalinska, J B ^b   Church, T ^c   Crawford, D ^d   Essink Bot, M L ^b   Goel, V ^e   De Koning, H J ^b   Maattanen L ^f   Pentikainen T ^g  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f FINNISH CANCER REGISTRY   (Finland)

^g VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Cost effectiveness; Prostate cancer; Quality of life; Screening

Indexed keywords

ANXIETY; CANCER MORTALITY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; HUMAN; LABORATORY DIAGNOSIS; LIFESPAN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SCREENING; SCREENING TEST;

EID: 0034772902     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00288-X     Document Type: Article

References (33)

1. Rationale for randomised trials of prostate cancer screening
2. Screening for prostate cancer: A decision analytic view
3. UICC Workshop on the evaluation of screening programmes for cancer
4. Ethics of a prostate cancer screening trial
5. Dimensions of quality of life expressed by men treated for metastatic prostate cancer
6. Baseline quality of life of patients with advanced prostate cancer
7. Differences in urologist and patient assessments of health-related quality of life in men with prostate cancer: Results of the CaPSURE database
8. Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE
9. Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial
10. Quality-adjusted survival (Q-TWIST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer
11. Quality of life in low-income patients with metastatic prostate cancer: Divergent and convergent validity of three instruments
12. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes study
13. Short-term effects of population-based screening for prostate cancer on health-related quality of life
14. Health related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment
15. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization
16. Health related quality of life effects of radical prostatectomy and primary radiotherapy for (screen-detected or clinically diagnosed) prostate cancer
17. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients
18. How reliable are relatives' retrospective reports of terminal illness? Patients' and relatives' accounts compared
19. The burden of illness of cancer: Economic cost and quality of life
20. A review of the use of health status measures in economic evaluation
21. Deriving a preference-based single index from the UK SF-36 health survey
22. Medical Outcomes Study Short Form 36: A possible source of utilities?
23. Quality-of-life outcomes in long-term survivors of advanced prostate cancer
24. Advanced prostate cancer: Course, care and cost implications
25. Adjusting for non-compliance and contamination in randomized clinical trials
26. A method for the analysis of randomized trials with compliance information: An application to MRFIT
27. The central role of the propensity score in observational studies for causal effects
28. More powerful randomization-based p-values in double-blind trials with non-compliance
29. A novel form of ascertainment bias in case-control studies of cancer screening
30. Construction of the patient-oriented prostate utility scale (PORPUS): A multiattribute health state classification system for prostate cancer
31. Economics and cancer [special issue]